Systemic lupus erythematosus

LE WE PMID CA

Systemic lupus erythematosus

2668

Systemischer Lupus Erythematosus

Aicardi Goutieres syndrome

AIM2

Antiinflammatory compounds

Antiphospholipid syndrome

APRIL

Arterial hypertension (BASKET)

Arthritis (rheumatoid)

Autoantibodies Anti alpha actinin

Autoantibodies Anti beta 2 glycoprotein I

Autoantibodies Anti dsDNA Anti ssDNA

Autoimmunity

B Cell (B1)

B Zelle L2pB1

BAFF

Belimumab ttBLyS

BLYS

CD180 RP105

Cyclophosphamide

Dendritic cell (Immunology)

Dendritic cell (Plasmacytoid)

DNA (Methylation)

Efferocytosis

Estrogen

Fatty acids (Omega3)

Genetics (GWAS Genome wide association study)

Heart (Arrhythmia)

Histone deacetylase

IFI16

Ifi200 protein family

Ifi202a

Ifi202b

Ifi203

Ifi204

Ifi205

IFIX

IgA nephropathy

Immunopsychiatry

Interferon alpha and preliminary (BASKET)

Interleukin17

Interleukin21

Interleukin6

Jaccoud s arthropathy

Kidney (C1q nephropathy)

Leukocyte (Extravasation and Trafficking)

Libman Sacks endocarditis

Macrophage activation syndrome

Mitochondria (Hyperpolarization)

Mitral valve (Regurgitation)

MNDA

MRL LPR mouse

MTOR

Neutropenia (autoimmune)

Osteoporosis

Pancreatitis (BASKET)

PD L2

Pregnancy (Diseases)

Prgnancy (High risk pregnancy)

PTPN22

Receptor (Antibody Fc)

Regulatory T cell

Reversible posterior cerebral edema

Reversible posterior leukoencephalopathy syndrome

Rituximab ttCD20

RNA (MicroRNA)

Rowell s syndrome

RP105

Statistics and trial design

Systemic lupus erythematosus

T cell (CD8pos)

T cell (double negative)

T Cell (Signal transduction)

Tacrolimus FK506

TLR7

TLR9

TNFAIP3 A20

Tolerance (Immunology)

Toll like receptor

TREX1

TWEAK Fn14

1993 1	Psychiatric symptoms in systemic lupus erythematosus: an update. [8475237] Psychosom Med 55(2): 219-28 (1993)
1972 2	The study of the psychiatric symptoms of systemic lupus erythematosus.. A critical review. [4556060] Psychosom Med 34(3): 199-206 (1972)
2006 3	Systemic lupus erythematosus. [16613963] BMJ 332(7546): 890-4 (2006)
1995 4	ABC of rheumatology. Systemic lupus erythematosus and lupus-like syndromes. [7767201] BMJ 310(6989): 1257-61 (1995)
1993 5	Diagnosis and treatment of systemic lupus erythematosus. [8401055] BMJ 307(6905): 663-6 (1993)
1979 6	Systemic lupus erythematosus: treatment and prognosis. [391327] Br Med J 2(6197): 1019-22 (1979)
1975 7	Editorial: Cerebral lupus. [124612] Br Med J 1(5957): 537-8 (1975)
1973 8	Mortality in systemic lupus erythematosus: a 10-year review. [4758576] Br Med J 4(5895): 772-4 (1973)
2009 9	Usefulness of ISN/RPS classification of lupus nephritis. [19194566] J Korean Med Sci 24 Suppl(-): S7-10 (2009)
2003 10	The pathogenesis of systemic lupus erythematosus. [14768716] Neth J Med 61(11): 343-6 (2003)
2003 11	Lupus nephritis: consequence of disturbed removal of apoptotic cells? [14628957] Neth J Med 61(8): 233-8 (2003)
2009 12	Lupus update: perspective and clinical pearls. [19188480] Cleve Clin J Med 76(2): 137-42 (2009)
2008 13	Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. [19936286] Curr Cardiol Rev 4(2): 116-22 (2008)
2006 14	Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. [17162363] Clin Dev Immunol 13(2-4): 203-8 (2006)
2006 15	The epigenetic face of systemic lupus erythematosus. [16751355] J Immunol 176(12): 7143-7 (2006)
2009 16	The role of extracellular DNA in autoimmunity in SLE. [19703007] Scand J Immunol 70(3): 175-83 (2009)
2006 17	Autoantibody determination in the diagnosis of systemic lupus erythematosus. [16918691] Scand J Immunol 64(3): 227-35 (2006)
2006 18	Regulatory T cells and systemic lupus erythematosus. [16918689] Scand J Immunol 64(3): 211-8 (2006)
2004 19	Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. [15238073] Scand J Immunol 60(1-2): 52-63 (2004)
2005 20	New therapies for systemic lupus erythematosus. [15807843] Clin Exp Immunol 140(2): 205-12 (2005)
1981 21	Current perspectives on serological reactions in SLE patients. [7021022] Clin Exp Immunol 44(1): 1-10 (1981)
2004 22	Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. [15131354] J Appl Genet 45(2): 237-48 (2004)
1994 23	Nephritogenic antibodies in MRL/lpr lupus mice: molecular characteristics in pathological and genetic aspects. [7809912] Tohoku J Exp Med 173(1): 65-74 (1994)
1994 24	Nephritogenic antibodies in lupus nephritis. [7809910] Tohoku J Exp Med 173(1): 31-41 (1994)
2008 25	EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. [17504841] Ann Rheum Dis 67(2): 195-205 (2008)
2006 26	Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. [16079164] Ann Rheum Dis 65(2): 144-8 (2006)
2005 27	Autoantibodies to opsonins of apoptotic cells in systemic lupus erythematosus. [16284341] Ann Rheum Dis 64(12): 1669-70 (2005)
2005 28	How to monitor SLE in routine clinical practice. [15769911] Ann Rheum Dis 64(4): 524-7 (2005)
2003 29	Treatment of severe proliferative lupus nephritis: the current state. [12922948] Ann Rheum Dis 62(9): 799-804 (2003)
2002 30	Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). [12006332] Ann Rheum Dis 61(6): 547-50 (2002)
1995 31	Controversies in lupus: nervous system involvement. [7748011] Ann Rheum Dis 54(3): 159-67 (1995)
1992 32	Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response? [1575582] Ann Rheum Dis 51(3): 358-61 (1992)
2009 33	How can we reduce the risk of serious infection for patients with systemic lupus erythematosus? [19960581] Arthritis Res Ther 11(5): 129 (2009)
2009 34	Developments in the clinical understanding of lupus. [19849817] Arthritis Res Ther 11(5): 245 (2009)
2009 35	Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects. [19591653] Arthritis Res Ther 11(3): 234 (2009)
2008 36	Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis. [19090960] Arthritis Res Ther 10(6): 229 (2008)
2008 37	Regulatory T cells in systemic lupus erythematosus: past, present and future. [19040771] Arthritis Res Ther 10(6): 227 (2008)
2008 38	Developments in the scientific understanding of lupus. [18947369] Arthritis Res Ther 10(5): 218 (2008)
2003 39	Microarray analysis of gene expression in lupus. [14680503] Arthritis Res Ther 5(6): 279-87 (2003)
2003 40	Systemic lupus erythematosus and the type I interferon system. [12718746] Arthritis Res Ther 5(2): 68-75 (2003)
1996 41	Cellular interactions in the lpr and gld models of systemic autoimmunity. [8934931] Adv Dent Res 10(1): 76-80 (1996)
2008 42	Lupus nephritis: the central role of nucleosomes revealed. [18187568] Am J Pathol 172(2): 275-83 (2008)
1995 43	Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. [7762914] Ann Intern Med 123(1): 42-53 (1995)
1995 44	Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. [7755231] Ann Intern Med 122(12): 940-50 (1995)
2006 45	Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis. [17163990] Arthritis Res Ther 8(6): R182 (2006)
2008 46	Cognitive dysfunction in systemic lupus erythematosus: past, present, and future. [18975345] Arthritis Rheum 58(11): 3286-98 (2008)
2008 47	Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. [18576314] Arthritis Rheum 58(7): 1892-9 (2008)
2008 48	Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus. [18311758] Arthritis Rheum 59(3): 332-7 (2008)
2007 49	Measurement of fatigue in systemic lupus erythematosus: a systematic review. [18050225] Arthritis Rheum 57(8): 1348-57 (2007)
2007 50	Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. [17599763] Arthritis Rheum 56(7): 2344-51 (2007)
2005 51	Pituitary hormones and systemic lupus erythematosus. [16320320] Arthritis Rheum 52(12): 3701-12 (2005)
2004 52	Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. [15248202] Arthritis Rheum 50(7): 2048-65 (2004)
2004 53	Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. [15188346] Arthritis Rheum 50(6): 1709-20 (2004)
2002 54	Choosing treatment for proliferative lupus nephritis. [12209498] Arthritis Rheum 46(8): 1981-3 (2002)
2002 55	What do we know about lupus membranous nephropathy? An analytic review. [12209494] Arthritis Rheum 47(4): 450-5 (2002)
2002 56	Abnormal T cell signal transduction in systemic lupus erythematosus. [12115215] Arthritis Rheum 46(5): 1139-54 (2002)
1999 57	The key role of nucleosomes in lupus. [10323438] Arthritis Rheum 42(5): 833-43 (1999)
1999 58	The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. [10211873] Arthritis Rheum 42(4): 599-608 (1999)
1996 59	Michael Mason Prize Essay 1995. Complement, immune complexes and systemic lupus erythematosus. [8624623] Br J Rheumatol 35(1): 5-23 (1996)
2008 60	Pulmonary and thrombotic manifestations of systemic lupus erythematosus. [18187752] Chest 133(1): 271-80 (2008)
2000 61	Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. [11035681] Chest 118(4): 1083-90 (2000)
2008 62	What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials? [18287258] Clin J Am Soc Nephrol 3(3): 895-8 (2008)
2007 63	Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. [17702723] Clin J Am Soc Nephrol 2(5): 968-75 (2007)
2007 64	Role of mycophenolate mofetil in the treatment of lupus nephritis. [17702717] Clin J Am Soc Nephrol 2(5): 879-82 (2007)
2006 65	New therapies for lupus nephritis. [17699298] Clin J Am Soc Nephrol 1(4): 863-8 (2006)
2004 66	Management of lupus nephritis: an update. [15466274] J Am Soc Nephrol 15(10): 2694-704 (2004)
1999 67	Lupus nephritis. [10215343] J Am Soc Nephrol 10(2): 413-24 (1999)
2003 68	Pathogenesis of systemic lupus erythematosus. [12835292] J Clin Pathol 56(7): 481-90 (2003)
2007 69	Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. [17405792] Nephrol Dial Transplant 22(7): 1933-42 (2007)
2006 70	Systemic lupus erythematosus. [16722594] Orphanet J Rare Dis 1(-): 6 (2006)
1993 71	Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE). [8234102] Postgrad Med J 69(814): 602-8 (1993)
2007 72	Ocular manifestations of systemic lupus erythematosus. [17681981] Rheumatology (Oxford) 46(12): 1757-62 (2007)
2005 73	Complement and its breakdown products in SLE. [15972354] Rheumatology (Oxford) 44(10): 1227-32 (2005)
2005 74	Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus. [15914499] Rheumatology (Oxford) 44(9): 1086-9 (2005)
2002 75	Long-term complications of systemic lupus erythematosus. [12364626] Rheumatology (Oxford) 41(10): 1095-100 (2002)
2002 76	The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. [12048287] Rheumatology (Oxford) 41(6): 619-30 (2002)
2002 77	The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. [12048286] Rheumatology (Oxford) 41(6): 605-18 (2002)
2000 78	Links between complement abnormalities and systemic lupus erythematosus. [10725062] Rheumatology (Oxford) 39(2): 133-41 (2000)
2000 79	Systemic lupus erythematosus-messages from experimental models. [10662869] Rheumatology (Oxford) 39(1): 18-27 (2000)
1999 80	A review of gastrointestinal manifestations of systemic lupus erythematosus. [10534541] Rheumatology (Oxford) 38(10): 917-32 (1999)
1985 81	Heart disease in systemic lupus erythematosus: diagnosis and management. [15227037] Tex Heart Inst J 12(1): 9-21 (1985)
2000 82	Pleuropulmonary manifestations of systemic lupus erythematosus. [10639536] Thorax 55(2): 159-66 (2000)
1975 83	Editorial: Pathogenesis of systemic lupus erythematosus. [1078744] West J Med 122(2): 157-8 (1975)
1975 84	Recent advances in the immunopathogenesis of systemic lupus erythematosus. [46657] West J Med 122(2): 130-44 (1975)
2005 85	Acute pancreatitis as an initial symptom of systemic lupus erythematosus: a case report and review of the literature. [16094728] World J Gastroenterol 11(30): 4766-8 (2005)
1997 86	Lupus nephritis. [9264014] Kidney Int 52(2): 538-58 (1997)
1994 87	Lupus nephritis: lessons from the path lab. [8196299] Kidney Int 45(3): 928-38 (1994)
1992 88	Induction and progression of experimental lupus nephritis: exploration of a pathogenetic pathway. [1593861] Kidney Int 41(1): 5-13 (1992)
1986 89	The treatment of lupus nephritis. [3537464] Kidney Int 30(5): 769-87 (1986)
2004 90	Imaging findings in systemic lupus erythematosus. [15256629] Radiographics 24(4): 1069-86 (2004)
2008 91	The clinical importance of lymphadenopathy in systemic lupus erythematosus. [19107085] Acta Reumatol Port 33(4): 402-6 (2008)
2008 92	Novel therapies in lupus - focus on nephritis. [18604181] Acta Reumatol Port 33(2): 157-69 (2008)
2010 93	European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. [19892750] Ann Rheum Dis 69(7): 1269-74 (2010)
2011 94	Disturbances of apoptotic cell clearance in systemic lupus erythematosus. [21371352] Arthritis Res Ther 13(1): 202 (2011)
2011 95	Chromatin as a target antigen in human and murine lupus nephritis. [21542875] Arthritis Res Ther 13(2): 214 (2011)
2003 96	B cell abnormalities in systemic lupus erythematosus. [15180894] Arthritis Res Ther 5 Suppl 4(-): S22-7 (2003)
2010 97	A new tool for detection of type I interferon activation in systemic lupus erythematosus. [20815919] Arthritis Res Ther 12(4): 138 (2010)
2010 98	Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. [20609263] Arthritis Res Ther 12(3): 210 (2010)
2010 99	The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. [20423534] Arthritis Res Ther 12(2): 207 (2010)
2010 100	Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes). [20441604] Arthritis Res Ther 12(2): 111 (2010)
2010 101	Identity of mysterious CD4+CD25-Foxp3+ cells in SLE. [20122288] Arthritis Res Ther 12(1): 101 (2010)
2009 102	The role of anti-alpha-actinin antibodies in the pathogenesis and monitoring of lupus nephritis. [20017900] Arthritis Res Ther 11(6): 137 (2009)
2009 103	Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis. [19939293] Arthritis Res Ther 11(6): 255 (2009)
2009 104	TWEAK: a novel biomarker for lupus nephritis? [19951398] Arthritis Res Ther 11(6): 133 (2009)
2004 105	Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. [15334435] Arthritis Rheum 51(4): 609-15 (2004)
2004 106	The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. [15529383] Arthritis Rheum 50(11): 3418-26 (2004)
2004 107	Cyclophosphamide for severe lupus nephritis: where are we now? [15593210] Arthritis Rheum 50(12): 3748-50 (2004)
2003 108	Sex hormones and systemic lupus erythematosus: review and meta-analysis. [12905462] Arthritis Rheum 48(8): 2100-10 (2003)
2003 109	Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms? [12571837] Arthritis Rheum 48(2): 300-12 (2003)
2009 110	Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? [19333929] Arthritis Rheum 60(4): 912-5 (2009)
2009 111	Systemic lupus erythematosus: a matter of life and death. [19479835] Arthritis Rheum 60(6): 1567-70 (2009)
2009 112	Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. [19877067] Arthritis Rheum 60(11): 3388-99 (2009)
2009 113	Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. [19714582] Arthritis Rheum 60(9): 2558-64 (2009)
2007 114	Systemic lupus erythematosus. [17974690] BMJ 335(7626): 933-6 (2007)
2006 115	Targeting of B cells in SLE: rationale and therapeutic opportunities. [17121490] Bull NYU Hosp Jt Dis 64(1-2): 51-6 (2006)
2010 116	Trials and tribulations in systemic lupus erythematosus. [20969548] Bull NYU Hosp Jt Dis 68(3): 175-8 (2010)
2007 117	B cell biology and dysfunction in SLE. [17922667] Bull NYU Hosp Jt Dis 65(3): 182-6 (2007)
2007 118	Biomarker discovery in human SLE nephritis. [17922668] Bull NYU Hosp Jt Dis 65(3): 187-93 (2007)
2007 119	Neuropsychiatric lupus: clinical and imaging aspects. [17922669] Bull NYU Hosp Jt Dis 65(3): 194-9 (2007)
2007 120	Cutaneous lupus: insights into pathogenesis and disease classification. [17922670] Bull NYU Hosp Jt Dis 65(3): 200-4 (2007)
2008 121	Lupus nephritis: histology, diagnosis, and treatment. [18937630] Bull NYU Hosp Jt Dis 66(3): 188-94 (2008)
2008 122	Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench. [18937629] Bull NYU Hosp Jt Dis 66(3): 184-7 (2008)
2008 123	The genetic contribution to systemic lupus erythematosus. [18937628] Bull NYU Hosp Jt Dis 66(3): 176-83 (2008)
2010 124	Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. [20572299] World J Gastroenterol 16(24): 2971-7 (2010)
2010 125	Updates on the treatment of lupus nephritis. [21051743] J Am Soc Nephrol 21(12): 2028-35 (2010)
2004 126	Reclassification of lupus glomerulonephritis: back to the future. [14747399] J Am Soc Nephrol 15(2): 501-3 (2004)
2009 127	Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. [19329762] J Am Soc Nephrol 20(4): 696-704 (2009)
2004 128	Distinguishing C1q nephropathy from lupus nephritis. [15004260] Nephrol Dial Transplant 19(6): 1420-6 (2004)
2004 129	Deranged removal of apoptotic cells: its role in the genesis of lupus. [14736945] Nephrol Dial Transplant 19(2): 282-5 (2004)
2009 130	How did cyclophosphamide become the drug of choice for lupus nephritis? [19056783] Nephrol Dial Transplant 24(2): 381-4 (2009)
2006 131	Looking backward: a review of the treatment of systemic lupus erythematosus in end-stage renal disease after a quarter of century. [16384832] Nephrol Dial Transplant 21(6): 1739 (2006)
2011 132	The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. [21331367] J Biomed Biotechnol 2011(-): 207504 (2011)
2011 133	Murine models of systemic lupus erythematosus. [21403825] J Biomed Biotechnol 2011(-): 271694 (2011)
2010 134	Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review. [20625508] J Biomed Biotechnol 2010(-): 686480 (2010)
2010 135	Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus. [20652041] J Biomed Biotechnol 2010(-): 294582 (2010)
2010 136	Interferon alpha in systemic lupus erythematosus. [20652065] J Biomed Biotechnol 2010(-): 948364 (2010)
2010 137	Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus. [20671931] J Biomed Biotechnol 2010(-): 457146 (2010)
2010 138	Anti-TNF-alpha therapies in systemic lupus erythematosus. [20625488] J Biomed Biotechnol 2010(-): 465898 (2010)
2010 139	Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus. [20617145] J Biomed Biotechnol 2010(-): 268436 (2010)
2010 140	Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. [20467470] J Biomed Biotechnol 2010(-): 365083 (2010)
2010 141	Cytokine networks in systemic lupus erythematosus. [20414360] J Biomed Biotechnol 2010(-): 676284 (2010)
2010 142	Biomarkers for lupus nephritis: a critical appraisal. [20414362] J Biomed Biotechnol 2010(-): 638413 (2010)
2010 143	IL-17 in systemic lupus erythematosus. [20379379] J Biomed Biotechnol 2010(-): 943254 (2010)
2010 144	Cytokines in systemic lupus erythematosus. [21603232] J Biomed Biotechnol 2010(-): 735169 (2010)
2010 145	Genetics of systemic lupus erythematosus: contributions of mouse models in the era of human genome-wide association studies. [20670601] Discov Med 10(50): 71-8 (2010)
2011 146	Treating lupus in the kidney: where are we now, and where are we going? [22031671] Discov Med 12(65): 341-9 (2011)
2010 147	Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? [21122473] Discov Med 10(54): 416-24 (2010)
2010 148	mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? [20350481] Discov Med 9(46): 173-8 (2010)
2010 149	Biologic therapy for systemic lupus erythematosus. [20102681] Discov Med 9(44): 20-3 (2010)
2009 150	The busy life of regulatory T cells in systemic lupus erythematosus. [19772836] Discov Med 8(40): 13-7 (2009)
2010 151	IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus. [20808864] PLoS One 5(8): e12280 (2010)
2010 152	The role of B cells in lupus pathogenesis. [19850148] Int J Biochem Cell Biol 42(4): 543-50 (2010)
2005 153	Cellular and molecular mechanisms of regulation of autoantibody production in lupus. [16126985] Ann N Y Acad Sci 1051(-): 433-41 (2005)
2008 154	Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. [18658205] Rheumatology (Oxford) 47(10): 1498-502 (2008)
2004 155	Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management. [12867578] Rheumatology (Oxford) 43(1): 7-12 (2004)
2003 156	Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. [12595613] Rheumatology (Oxford) 42(2): 214-22 (2003)
2009 157	Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not! [19155279] Rheumatology (Oxford) 48(4): 332-41 (2009)
2008 158	Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma. [18084001] Rheumatology (Oxford) 47(3): 256-62 (2008)
2008 159	Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials. [18577549] Rheumatology (Oxford) 47(9): 1367-72 (2008)
2008 160	Challenges of lupus pregnancies. [18504287] Rheumatology (Oxford) 47 Suppl 3(-): iii9-12 (2008)
2006 161	Moderate and severe neutropenia in patients with systemic lupus erythematosus. [16484291] Rheumatology (Oxford) 45(8): 994-8 (2006)
2009 162	Osteoporosis in patients with systemic lupus erythematosus. [19891237] Isr Med Assoc J 11(8): 486-91 (2009)
2008 163	A novel synthetic peptide for the specific treatment of lupus: clinical effects and mechanism of action. [18300570] Isr Med Assoc J 10(1): 40-2 (2008)
2008 164	The story of the 16/6 idiotype and systemic lupus erythematosus. [18300569] Isr Med Assoc J 10(1): 37-9 (2008)
2008 165	Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis. [18451582] Intern Med 47(9): 867-75 (2008)
2004 166	Conference report--lupus nephritis: diagnosis, therapy, and outcomes. [15520647] MedGenMed 6(3): 23 (2004)
2010 167	Lupus band test. [20445312] Indian J Dermatol Venereol Leprol 76(3): 298-300 (2010)
2010 168	Review article: systemic lupus erythematosus: a review for anesthesiologists. [20601448] Anesth Analg 111(3): 665-76 (2010)
2003 169	Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity. [12605690] Clin Exp Immunol 131(3): 396-7 (2003)
2009 170	Interleukin-17 and systemic lupus erythematosus: current concepts. [19604260] Clin Exp Immunol 157(2): 209-15 (2009)
2012 171	Imaging assessment of cardiovascular disease in systemic lupus erythematosus. [22110536] Clin Dev Immunol 2012(-): 694143 (2012)
2012 172	RP105-negative B cells in systemic lupus erythematosus. [21941580] Clin Dev Immunol 2012(-): 259186 (2012)
2010 173	Targeting Toll-like receptors for treatment of SLE. [20886024] Mediators Inflamm 2010(-): - (2010)
2004 174	Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. [14994382] J Rheumatol 31(3): 419-21 (2004)
2004 175	The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease? [15517616] J Rheumatol 31(11): 2093-8 (2004)
2007 176	Renal biopsy at the onset of clinical lupus nephritis: can it yield useful information? [17304650] J Rheumatol 34(2): 256-8 (2007)
2006 177	Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure. [16881102] J Rheumatol 33(8): 1464-6 (2006)
2009 178	Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. [19808788] Hum Mol Genet 18(R2): R130-6 (2009)
2009 179	Pancreatitis and systemic lupus erythematosus. [19785498] Rev Esp Enferm Dig 101(8): 571-9 (2009)
2011 180	HDAC inhibition in lupus models. [21327298] Mol Med 17(5-6): 417-25 (2011)
2009 181	Biomarkers for lupus nephritis: the quest continues. [19729426] Clin J Am Soc Nephrol 4(11): 1858-65 (2009)
2010 182	The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus. [20360925] Clinics (Sao Paulo) 65(3): 327-33 (2010)
2008 183	Vasculopathy and vasculitis in systemic lupus erythematosus. [18405174] Pol Arch Med Wewn 118(1-2): 57-63 (2008)
2010 184	Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. [20347645] Semin Nephrol 30(2): 164-76 (2010)
2007 185	Neuroimmunopathology in a murine model of neuropsychiatric lupus. [17223198] Brain Res Rev 54(1): 67-79 (2007)
2007 186	Nitric oxide, mitochondrial hyperpolarization, and T cell activation. [17462531] Free Radic Biol Med 42(11): 1625-31 (2007)
2010 187	Advances in drug therapy for systemic lupus erythematosus. [21114845] BMC Med 8(-): 77 (2010)
2010 188	Mouse models of systemic lupus erythematosus reveal a complex pathogenesis. [20448279] Vet Pathol 47(4): 664-76 (2010)
2005 189	Demographics and presenting clinical features of childhood systemic lupus erythematosus. [16100891] S Afr Med J 95(6): 424-7 (2005)
2009 190	Lupus erythematosus masquerading as erythema multiforme: does Rowell syndrome really exist? [19336022] Dermatol Online J 15(2): 5 (2009)
2007 191	The Hopkins Lupus Pregnancy Center: ten key issues in management. [17499704] Rheum Dis Clin North Am 33(2): 227-35, v (2007)
2007 192	Lupus activity in pregnancy. [17499705] Rheum Dis Clin North Am 33(2): 237-52, v (2007)
2007 193	Lupus erythematosus gyratus repens. [17324834] Eur J Dermatol 17(1): 79-82 (2007)
2010 194	Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature. [20331896] J Cardiothorac Surg 5(-): 13 (2010)
2011 195	Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review. [21350606] Cardiol Res Pract 2011(-): 578390 (2011)
2009 196	Pathogenesis of kidney disease in systemic lupus erythematosus. [19584729] Curr Opin Rheumatol 21(5): 489-94 (2009)
2009 197	The search for lupus biomarkers. [19591781] Best Pract Res Clin Rheumatol 23(4): 507-23 (2009)
2009 198	Malignancy in systemic lupus erythematosus: what have we learned? [19591783] Best Pract Res Clin Rheumatol 23(4): 539-47 (2009)
2011 199	Current views on etiopathogenesis of systemic lupus erythematosus. [22100802] Postepy Hig Med Dosw (Online) 65(0): 683-703 (2011)
2010 200	Arrhythmias in systemic lupus erythematosus. [21125143] Rev Bras Reumatol 50(1): 81-9 (2010)
2007 201	Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. [17437489] Exp Dermatol 16(5): 454-63 (2007)
2010 202	T cells as therapeutic targets in SLE. [20458333] Nat Rev Rheumatol 6(6): 317-25 (2010)
2011 203	Clearing the complexity: immune complexes and their treatment in lupus nephritis. [21694945] Int J Nephrol Renovasc Dis 4(-): 17-28 (2011)
2010 204	Clinical outcome measures for cutaneous lupus erythematosus. [20693208] Lupus 19(9): 1137-43 (2010)
2004 205	Rationale for interleukin-6 blockade in systemic lupus erythematosus. [15230289] Lupus 13(5): 339-43 (2004)
2010 206	Understanding the epidemiology and progression of systemic lupus erythematosus. [19136143] Semin Arthritis Rheum 39(4): 257-68 (2010)
2010 207	Dendritic cells in systemic lupus erythematosus. [20367140] Int Rev Immunol 29(2): 184-209 (2010)
2008 208	Interferon alpha-induced lupus: proof of principle. [18525429] J Clin Rheumatol 14(3): 131-2 (2008)
2008 209	Neuropsychiatric systemic lupus erythematosus reconsidered. [18200006] Nat Clin Pract Rheumatol 4(3): 112-3 (2008)
2008 210	Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis. [18521755] Neuropsychol Rev 18(2): 149-66 (2008)
2010 211	Neurologic manifestations of systemic lupus erythematosus in children and adults. [19932376] Neurol Clin 28(1): 61-73 (2010)
2010 212	Advances in lupus stemming from the parent-into-F1 model. [20362509] Trends Immunol 31(6): 236-45 (2010)
2005 213	SLE: translating lessons from model systems to human disease. [16153890] Trends Immunol 26(11): 572-9 (2005)
2011 214	Cause of systemic lupus erythematosus: a novel self-organized criticality theory of autoimmunity. [22014010] Expert Rev Clin Immunol 7(6): 715-7 (2011)
2010 215	Recent advances in the genetics of systemic lupus erythematosus. [20441431] Expert Rev Clin Immunol 6(3): 461-79 (2010)
2010 216	Anticytokine therapies in systemic lupus erythematosus. [20636010] Immunotherapy 2(4): 575-82 (2010)
2009 217	Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus? [18938110] Clin Immunol 130(2): 111-22 (2009)
2010 218	Targeting B cells with biologics in systemic lupus erythematosus. [20919800] Expert Opin Biol Ther 10(11): 1555-61 (2010)
2010 219	Pathogenesis of human systemic lupus erythematosus: recent advances. [20138006] Trends Mol Med 16(2): 47-57 (2010)
2009 220	The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus. [18992852] Autoimmun Rev 8(4): 320-4 (2009)
2010 221	Pathways: Strategies for susceptibility genes in SLE. [20144911] Autoimmun Rev 9(7): 473-6 (2010)
2009 222	Overview of signal processing by the immune system in systemic lupus erythematosus. [18722560] Autoimmun Rev 8(3): 177-8 (2009)
2009 223	Aberrant T cell ERK pathway signaling and chromatin structure in lupus. [18723128] Autoimmun Rev 8(3): 196-8 (2009)
2009 224	Altered B cell receptor signaling in human systemic lupus erythematosus. [18723129] Autoimmun Rev 8(3): 209-13 (2009)
2009 225	Metabolic control of T cell activation and death in SLE. [18722557] Autoimmun Rev 8(3): 184-9 (2009)
2009 226	Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. [18722558] Autoimmun Rev 8(3): 204-8 (2009)
2008 227	Novel molecular targets in the treatment of systemic lupus erythematosus. [18190888] Autoimmun Rev 7(3): 256-61 (2008)
2008 228	Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice. [18817829] Hum Immunol 69(11): 790-6 (2008)
2008 229	Inhibitory CD8+ T cells in autoimmune disease. [18812196] Hum Immunol 69(11): 781-9 (2008)
2009 230	The pathophysiology of hypertension in systemic lupus erythematosus. [19158408] Am J Physiol Regul Integr Comp Physiol 296(4): R1258-67 (2009)
2011 231	An update on belimumab for the treatment of lupus. [21383914] Biologics 5(-): 33-43 (2011)
2010 232	n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis. [20189790] Prostaglandins Leukot Essent Fatty Acids 82(4-6): 251-8 (2010)
2009 233	Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. [19387456] Genes Immun 10(5): 470-7 (2009)
2009 234	Fcgamma receptors: structure, function and role as genetic risk factors in SLE. [19421223] Genes Immun 10(5): 380-9 (2009)
2003 235	Alterations in leucocyte trafficking in lupus-prone mice: an examination of the MRL/faslpr mouse. [12969327] Immunol Cell Biol 81(5): 390-6 (2003)
2008 236	Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. [18598717] Immunol Lett 119(1-2): 32-41 (2008)
2010 237	Key role of ERK pathway signaling in lupus. [19961364] Autoimmunity 43(1): 17-22 (2010)
2010 238	The biology of reactive intermediates in systemic lupus erythematosus. [20001422] Autoimmunity 43(1): 56-63 (2010)
2010 239	Regulation of autoreactive B cell responses to endogenous TLR ligands. [20014959] Autoimmunity 43(1): 76-83 (2010)
2010 240	Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. [20014977] Autoimmunity 43(1): 84-97 (2010)
2007 241	PTPN22: its role in SLE and autoimmunity. [18075792] Autoimmunity 40(8): 582-90 (2007)
2008 242	Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond. [18432408] Autoimmunity 41(4): 278-86 (2008)
2009 243	Why can't we find a new treatment for SLE? [19329279] J Autoimmun 32(3-4): 223-30 (2009)
2010 244	EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. [20724309] Ann Rheum Dis 69(12): 2074-82 (2010)
2011 245	L2pB1: a new player in autoimmunity. [21195478] Mol Immunol 48(11): 1292-300 (2011)
2010 246	The management of peripheral blood cytopenias in systemic lupus erythematosus. [20823093] Rheumatology (Oxford) 49(12): 2243-54 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Systemic lupus erythematosus.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Systemic lupus erythematosus.php on line 92